Literature DB >> 6260525

Postsynaptic inhibitory actions of catecholamines and opioid peptides in the bed nucleus of the stria terminalis.

S Sawada, C Yamamoto.   

Abstract

Effects of catecholamines, enkephalins and related compounds on electrical activity of the bed nucleus of stria terminalis (BST) were studied in vitro on thin BST sections prepared from guinea pig brains. Norepinephrine (NE) and epinephrine (E) suppressed field potentials elicited by a single shock to the stria terminalis (ST). The effects of NE and E were mimicked by phenylephrine and blocked by phenoxybenzamine. Isoproterenol and dichloroisoproterenol were without effect. NE and E suppressed the spontaneous firing of BST neurons and discharges elicited by ST stimulation. Dopamine was a less potent depressant. [D-Ala2]-Met-enkephalinamide (EKA) suppressed the field potentials and spike discharges elicited by ST stimulation. Spikes occurring spontaneously or during administration of glutamate were also suppressed by EKA. The action of EKA was blocked by naloxone. Late inhibition induced by stimulation of the lateral division of the ST was blocked by naloxone in about a third of the neurons examined. These results indicate that norepinephrine suppresses the activity of BST neurons by activating postsynaptic alpha-receptors. It is also suggested that opioid peptides mediate inhibitory control of the amygdala over the BST.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260525     DOI: 10.1007/bf00238883

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  21 in total

1.  Effects of methionine-enkephalin and leucine-enkephalin compared with those of morphine on brainstem neurones in cat.

Authors:  J P Gent; J H Wolstencroft
Journal:  Nature       Date:  1976-06-03       Impact factor: 49.962

2.  The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies.

Authors:  M Segal; F E Bloom
Journal:  Brain Res       Date:  1974-05-31       Impact factor: 3.252

3.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

4.  Differential effects of lesions in the amygdala, periamygdaloid cortex, and stria terminalis on aggressive behaviors in rats.

Authors:  K A Miczek; T Brykczynski; S P Grossman
Journal:  J Comp Physiol Psychol       Date:  1974-10

Review 5.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

6.  Effects of morphine and its antagonists on release of cerebral cortical acetylcholine.

Authors:  K Jhamandas; C Pinsky; J W Phillis
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

7.  Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor.

Authors:  M A Rogawski; G K Aghajanian
Journal:  Brain Res       Date:  1980-01-27       Impact factor: 3.252

8.  Histamine synthesizing afferents within the amygdaloid complex and bed nucleus of the stria terminalis of the rat.

Authors:  Y Ben-Ari; G Le Gal La Salle; G Barbin; J C Schwartz; M Garbarg
Journal:  Brain Res       Date:  1977-12-16       Impact factor: 3.252

9.  Regional distribution of met-enkephalin within the amygdaloid complex and bed nucleus of the stria terminals.

Authors:  C Gros; P Pradelles; J Humbert; F Dray; G Le Gal La Salle; Y Ben-Ari
Journal:  Neurosci Lett       Date:  1978-11       Impact factor: 3.046

10.  Electrical activity recorded from thin sections of the bed nucleus of the stria terminalis, and the effects of neurotensin.

Authors:  S Sawada; S Takada; C Yamamoto
Journal:  Brain Res       Date:  1980-04-28       Impact factor: 3.252

View more
  8 in total

1.  Demonstration of distinct corticotropin releasing factor--containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat.

Authors:  C F Phelix; W K Paull
Journal:  Histochemistry       Date:  1990

2.  Glutamatergic and gabaergic ventral BNST neurons differ in their physiological properties and responsiveness to noradrenaline.

Authors:  Nur Zeynep Gungor; Ryo Yamamoto; Denis Pare
Journal:  Neuropsychopharmacology       Date:  2018-04-20       Impact factor: 7.853

3.  Mu-opioid receptor densities are depleted in regions implicated in agonistic and sexual behavior in male European starlings (Sturnus vulgaris) defending nest sites and courting females.

Authors:  Cynthia A Kelm; Robin M Forbes-Lorman; Catherine J Auger; Lauren V Riters
Journal:  Behav Brain Res       Date:  2010-12-13       Impact factor: 3.332

4.  The NMDA-NR1 receptor subunit and the mu-opioid receptor are expressed in somatodendritic compartments of central nucleus of the amygdala neurons projecting to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2011-12-29       Impact factor: 5.330

5.  Both alpha1 and alpha2-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the bed nucleus of the stria terminal of rats.

Authors:  C C Crestani; F H F Alves; L B Resstel; F M A Corrêa
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 6.  Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward.

Authors:  Stephanie A Flavin; Danny G Winder
Journal:  Neuropharmacology       Date:  2013-03-04       Impact factor: 5.250

Review 7.  Modulation of glutamatergic synaptic transmission in the bed nucleus of the stria terminalis.

Authors:  Zoé Anastasia McElligott; Danny G Winder
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-06-11       Impact factor: 5.067

8.  Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review.

Authors:  Carlos C Crestani; Fernando Hf Alves; Felipe V Gomes; Leonardo Bm Resstel; Fernando Ma Correa; James P Herman
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.